APN01

Recombinant human angiotensin-converting enzyme 2 · Apeiron Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APN01, covering 2009-12-31 to 2009-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) [Phase 1]